A detailed history of Prime Capital Investment Advisors, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Prime Capital Investment Advisors, LLC holds 9,750 shares of DXCM stock, worth $758,550. This represents 0.01% of its overall portfolio holdings.

Number of Shares
9,750
Holding current value
$758,550
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

BUY
$64.0 - $116.06 $624,000 - $1.13 Million
9,750 New
9,750 $653,000
Q1 2024

May 14, 2024

SELL
$114.22 - $140.1 $688,746 - $844,803
-6,030 Reduced 76.55%
1,847 $256,000
Q4 2023

Jan 24, 2024

BUY
$75.49 - $124.16 $357,143 - $587,400
4,731 Added 150.38%
7,877 $977,000
Q3 2023

Nov 09, 2023

BUY
$86.06 - $137.93 $270,744 - $433,927
3,146 New
3,146 $293,000
Q1 2023

May 05, 2023

BUY
$104.0 - $122.92 $524,160 - $619,516
5,040 New
5,040 $585,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Prime Capital Investment Advisors, LLC Portfolio

Follow Prime Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prime Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prime Capital Investment Advisors, LLC with notifications on news.